Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


COPYRIGHT © 2003 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marino, W. D.
Right arrow Articles by Corpuz, M. O.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Marino, W. D.
Right arrow Articles by Corpuz, M. O.

Ventilator-Associated Pneumonia


Monday, October 27, 2003

8:00 AM - 9:30 AM

Treatment of Ventilator-Associated Pneumonia (VAP) Caused by Highly Resistant Gram-Negative Bacteria With Local Instillation of Colistin

William D. Marino, MD, FCCP*, Hakop H. Hrachian, MD, Natalia Chkrebtii, MD, Anna W. Komorowski, MD, Sreenivas D. Gunturu, MD and Marilou O. Corpuz, MD

University Hospital, Our Lady of Mercy Medical Center, Bronx, NY

PURPOSE: We have substantial experience with suppression of bacterial growth in chronic lung disease by the use of colistin aerosol. VAP with highly resistant Gram negative organisms has become a major clinical problem in the last few years. We report here the results of our efforts to treat such infections with direct instillation of colistin solution in patients with artificial airways.

METHODS: Retrospective chart review of 11 patients in our institution who had VAP with Gram negative bacilli resistant to all available systemic antibiotics. Patients were given colistin by direct instillation of 50 mg in 50 ml of saline via catheters passed through their endotracheal or tracheostomy tube, localized according to the distribution of pulmonary infiltrates. Roentgenographic, hemodynamic, microbiologic, hematologic and serum chemistry data before and after colistin instillation were recorded, as were vital signs, demographics and outcome. No antibiotic therapy other than local colistin was administered.

RESULTS: Of the 11 patients who were treated with local instillation of colistin, 8 recovered and were discharged, while 3 died. All patients improved or completely resolved their pulmonary infiltrates after colistin instillation except one patient whose post-treatment chest x-ray was not conclusive due to fluid overload. Sputum cultures were sterilized in all 11 patients. Fever and systemic signs resolved in all patients. WBC count improved significantly in 8 patients. No toxicity was detected. The 3 deaths were unrelated to infection.

CONCLUSION: Local instillation of colistin is an effective treatment for VAP caused by highly resistant Gram negative organisms.

CLINICAL IMPLICATIONS: This treatment should be considered in severe pulmonary infections caused by highly resistant Gram negative organisms, especially when they occur in patients with artificial airways.

DISCLOSURE: W.D. Marino, None.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.